JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109388

重组Anti-PIAS1抗体[EPR2580(2)]

Anti-PIAS1 antibody [EPR2580(2)]

5

(3 Reviews)

|

(20 Publications)

Rabbit Recombinant Monoclonal PIAS1 antibody. Suitable for IHC-P, WB, ICC/IF and reacts with Human samples. Cited in 20 publications.

查看别名

DDXBP1, PIAS1, E3 SUMO-protein ligase PIAS1, DEAD/H box-binding protein 1, E3 SUMO-protein transferase PIAS1, Gu-binding protein, Protein inhibitor of activated STAT protein 1, RNA helicase II-binding protein, GBP

7 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

Immunohistochemical analysis of paraffin-embedded Human colon tissue using 1/100 ab109388.

Perform heat mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • ICC/IF

Lab

Immunocytochemistry/ Immunofluorescence - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

Immunocytochemistry/ Immunofluorescence analysis of HeLa (human cervix adenocarcinoma epithelial cell) cells labeling PIAS1 with purified ab109388 at 1/500 dilution (4.6 μg/mL). Cells were fixed in 100% Methanol. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain.

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • WB

Unknown

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

All lanes:

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (ab109388) at 1/1000 dilution

Lane 1:

HepG2 cell lysates at 10 µg

Lane 2:

Jurkat cell lysates at 10 µg

Lane 3:

HEK-293 cell lysates at 10 µg

Lane 4:

Daudi cell lysates at 10 µg

Predicted band size: 71 kDa

false

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • WB

Lab

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

Exposure time :

Lane 1 : 10 seconds.

Lane 2 : 1 minute.

Blocking and dilution buffer : 5% NFDM /TBST.

Lane 1:

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (ab109388) at 1/500 dilution

Lane 2:

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (ab109388) at 1/2000 dilution

All lanes:

Recombinant Human PIAS1 protein (<a href='/products/unavailable/recombinant-human-pias1-protein-ab152888'>ab152888</a>) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution

Predicted band size: 71 kDa

Observed band size: 98 kDa

false

OI-RD Scanning - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • WB

CiteAb

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

Western Blotting using Anti-PIAS1 antibody [EPR2580(2)], ab109388. Publication image from Chiou, H. Y. et al., 2014, J Biomed Sci, 24894488. Legend direct from paper.

PIAS1 enhances the suppressing effect of Hes-1 on GADD45α expression that is blocked by Hes-1 3KR. Different doses of Flag-PIAS1WT or Flag-PIAS1W372A plasmid was co-transfected with Myc-SUMO-1 and various doses of Flag-Hes-1WT or Flag-Hes-1 3KR plasmid together with 0.4 µg of GADD45α promoter construct to HEK293T cells for determination of (A) GADD45α promoter activity and (B) GADD45α mRNA level by real-time PCR. (C) Different doses of Flag-PIAS1WT or Flag-PIAS1W372A plasmid was co-transfected with various doses of Flag-Hes-1WT or Flag-Hes-1 3KR plasmid to HEK293T cells and western blot against GADD45α and Flag was performed. The quantified result is shown on the right panel. (D) Two sets of PIAS1 siRNA and 0.4 µg of GADD45α promoter construct were transfected to HEK293T cells and GADD45α promoter activity was determined 48 h later. Two sets of PIAS1 siRNA were transfected to HEK293T cells and (E) GADD45α mRNA level and (F) GADD45α protein level were determined 48 h later. The effectiveness of PIAS1 siRNA transfection is confirmed by western blot against PIAS1. (G) Two doses of Flag-GADD45α plasmid was transfected to cells with the addition of different concentrations of H2O2 and cell apoptosis was determined by TUNEL assay. Western blot against the Flag-tag confirms plasmid transfection and expression. (H) Two concentrations of GADD45α siRNA was transfected to HEK293T cells with the addition of different concentrations of H2O2 and cell apoptosis was determined by TUNEL assay. Western blot against GADD45α confirms the effectiveness of GADD45α siRNA transfection. Data are expressed as that in Figure 6. Each experiment was performed twice. *p < 0.05, **p < 0.01 and # p < 0.001.

false

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)
  • WB

CiteAb

Western blot - Anti-PIAS1 antibody [EPR2580(2)] (AB109388)

Western Blotting using Anti-PIAS1 antibody [EPR2580(2)], ab109388. Publication image from Chiou, H. Y. et al., 2014, J Biomed Sci, 24894488. Legend direct from paper.

H2O2 enhances the SUMOylation of Hes-1. (A) Flag-Hes-1WT plasmid was transfected to HEK293T cells with the addition of different concentrations of H2O2 and the cell lysate was immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Hes-1 (left) or anti-SUMO-1 (right) antibody. (B) Flag-Hes-1WT plasmid was transfected to HEK293T cells with the addition of 0.2 mM H2O2 for different time periods. The cell lysate was immunoprecipitated with anti-Flag antibody and immunoblotted with anti-Hes-1 (left) or anti-SUMO-1 (right) antibody. (C) Myc-SUMO-1 plasmid was transfected to HEK293T cells with the addition of 0.2 mM H2O2 for 4 h. The cell lysate was immunoprecipitated with anti-Myc antibody and immunoblotted with anti-Hes-1 and anti-SUMO-1 antibody. (D) H2O2 (0.2 mM) was added to HEK293T cells for different time periods and the cell lysate was subject to western blot against pSer-90 PIAS1 and PIAS1 (upper panel). Flag-Hes-1WT plasmid was transfected to HEK293T cells with co-transfection of EGFP-PIAS1WT or EGFP-PIAS1S90A plasmid and with the addition of H2O2 for 4 h and the cell lysate was immunoprecipitated with anti-Flag antibody and immunoblotted with antibodies against PIAS1 and Flag. Western blot against EGFP and Flag for cell lysates only was used as a control for transfection and expression (lower panel). (E) Flag-Hes-1WT plasmid was co-transfected with EGFP-PIAS1 and Myc-SUMO-1 plasmids, and H2O2 was added to some of these groups for 4 h. The phosphatase inhibitor CIP (20 U/ml) was also added to some of these groups. The cell lysates were immunoprecipitated with anti-Flag antibody and immunoblotted with anti-PIAS1 antibody. Western blot against Flag, PIAS1 and SUMO-1 for cell lysates only was used as loading controls. The sumoylated Hes-1 bands are shown in the bracket. Each experiment was performed twice.

false

不同偶联物与剂型 (10)

  • Carrier free

    Anti-PIAS1 antibody [EPR2580(2)] - BSA and Azide free

  • 660 APC

    APC Anti-PIAS1 antibody [EPR2580(2)]

  • HRP

    HRP Anti-PIAS1 antibody [EPR2580(2)]

  • 519 Alexa Fluor® 488

    Alexa Fluor® 488 Anti-PIAS1 antibody [EPR2580(2)]

  • 603 Alexa Fluor® 568

    Alexa Fluor® 568 Anti-PIAS1 antibody [EPR2580(2)]

  • 565 Alexa Fluor® 555

    Alexa Fluor® 555 Anti-PIAS1 antibody [EPR2580(2)]

  • 665 Alexa Fluor® 647

    Alexa Fluor® 647 Anti-PIAS1 antibody [EPR2580(2)]

  • 617 Alexa Fluor® 594

    Alexa Fluor® 594 Anti-PIAS1 antibody [EPR2580(2)]

  • 578 PE

    PE Anti-PIAS1 antibody [EPR2580(2)]

  • 775 Alexa Fluor® 750

    Alexa Fluor® 750 Anti-PIAS1 antibody [EPR2580(2)]

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR2580(2)

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

WB, ICC/IF, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p>Heat up to 98 degrees C, below boiling, and then let cool for 10-20 min.</p> Perform heat-mediated antigen retrieval via the pressure cooker method before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/500", "ICCIF-species-notes": "<p></p>" }, "Mouse": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Rat": { "IHCP-species-checked": "predicted", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

产品详情

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 0.1% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Stable for 12 months at -20°C

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

PIAS1 also known as Protein Inhibitor of Activated STAT 1 functions as a E3 SUMO-protein ligase which regulates protein function and localization through sumoylation. It has a molecular mass of approximately 70 kDa. PIAS1 is widely expressed in a variety of tissues indicating its involvement in diverse cellular functions. This protein binds to target proteins and modulates their activity impacting how cells respond to different stimuli.
Biological function summary

PIAS1 influences transcription regulation and gene expression. It acts as a transcriptional co-regulator by interacting with various transcription factors and modulating their activity. PIAS1 is part of multiprotein complexes that mediate these regulatory processes. Its activity is important for maintaining a balanced gene expression which if uncontrolled may result in abnormal cell behavior.

Pathways

PIAS1 plays an important role in signal transduction pathways such as the JAK/STAT pathway and the NF-kB signaling pathway. It interacts with proteins like STAT an important component in these pathways to regulate immune responses and cell growth. PIAS1 modulates the activity of these pathways in part by the covalent attachment of the small ubiquitin-like modifier (SUMO) proteins demonstrating its importance in cellular signaling networks.

PIAS1 relates closely to cancer progression and autoimmune diseases. Abnormal PIAS1 function or expression has links to certain cancers due to its role in controlling cell proliferation and differentiation. In autoimmune disorders PIAS1 affects immune regulation through its interaction with Signal Transducer and Activator of Transcription proteins showing altered activity in diseases like rheumatoid arthritis. Understanding PIAS1's contributions to these pathological states helps in developing targeted therapies.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 15280358, PubMed : 21965678, PubMed : 36050397). Catalyzes sumoylation of various proteins, such as CEBPB, MRE11, MTA1, PTK2, PML and ZNF76 (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 15280358, PubMed : 21965678, PubMed : 36050397). Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway (PubMed : 11583632, PubMed : 11867732). In vitro, binds A/T-rich DNA (PubMed : 15133049). The effects of this transcriptional coregulation, transactivation or silencing, may vary depending upon the biological context (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 21965678, PubMed : 36050397). Mediates sumoylation of MRE11, stabilizing MRE11 on chromatin during end resection (PubMed : 36050397). Sumoylates PML (at 'Lys-65' and 'Lys-160') and PML-RAR and promotes their ubiquitin-mediated degradation (By similarity). PIAS1-mediated sumoylation of PML promotes its interaction with CSNK2A1/CK2 which in turn promotes PML phosphorylation and degradation (By similarity). Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation (PubMed : 21965678). Plays a dynamic role in adipogenesis by promoting the SUMOylation and degradation of CEBPB (By similarity). Mediates the nuclear mobility and localization of MSX1 to the nuclear periphery, whereby MSX1 is brought into the proximity of target myoblast differentiation factor genes (By similarity). Also required for the binding of MSX1 to the core enhancer region in target gene promoter regions, independent of its sumoylation activity (By similarity). Capable of binding to the core enhancer region TAAT box in the MYOD1 gene promoter (By similarity).. (Microbial infection) Restricts Epstein-Barr virus (EBV) lytic replication by acting as an inhibitor for transcription factors involved in lytic gene expression (PubMed : 29262325). The virus can use apoptotic caspases to antagonize PIAS1-mediated restriction and express its lytic genes (PubMed : 29262325).
See full target information PIAS1

文献 (20)

Recent publications for all applications. Explore the full list and refine your search

Oncology reports 53: PubMed39918019

2025

Cysteine‑ and glycine‑rich protein 2: A vital regulator that inhibits necroptosis glioma cell by activating the JAK‑STAT1 pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Dongsheng Lv,Xu Han,Liang Hao,Zhimin Sun,Aobo Zhang,Jing Liu,Liang Liu,Liqiang Liu

Heliyon 10:e24743 PubMed38617924

2024

Protein inhibitor of activated STAT1 (PIAS1) alleviates cerebral infarction and inflammation after cerebral ischemia in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Mingyang Wang,Pingzhi Wang,Bo Li,Guohu Zhao,Nan Zhang,Ruifeng Cao

Nature communications 14:3887 PubMed37393345

2023

SUMOylation of Rho-associated protein kinase 2 induces goblet cell metaplasia in allergic airways.

Applications

Unspecified application

Species

Unspecified reactive species

Dan Tan,Meiping Lu,Yuqing Cai,Weibo Qi,Fugen Wu,Hangyang Bao,Meiyu Qv,Qiangqiang He,Yana Xu,Xiangzhi Wang,Tingyu Shen,Jiahao Luo,Yangxun He,Junsong Wu,Lanfang Tang,Muhammad Qasim Barkat,Chengyun Xu,Ximei Wu

Aging 14:3529-3539 PubMed35460552

2022

NRIP1 aggravates lung injury caused by in mice by increasing PIAS1 ubiquitination.

Applications

Unspecified application

Species

Unspecified reactive species

Miaoyi Huang,Jianying Li,Jie Bai,Xusheng Du,Hua Guo,Bo Wang,Jiru Xu

PLoS pathogens 18:e1010446 PubMed35377920

2022

PIAS1-mediated SUMOylation of influenza A virus PB2 restricts viral replication and virulence.

Applications

Unspecified application

Species

Unspecified reactive species

Guangwen Wang,Yuhui Zhao,Yuan Zhou,Li Jiang,Libin Liang,Fandi Kong,Ya Yan,Xuyuan Wang,Yihan Wang,Xia Wen,Xianying Zeng,Guobin Tian,Guohua Deng,Jianzhong Shi,Liling Liu,Hualan Chen,Chengjun Li

Movement disorders : official journal of the Movement Disorder Society 37:767-777 PubMed34951052

2021

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Hua Lee,Yu-Shuen Tsai,Che-Chang Chang,Chun-Chen Ho,Hsiu-Ming Shih,Hui-Mei Chen,Hsing-Lin Lai,Chia-Wei Lee,Yi-Chung Lee,Yi-Chu Liao,Ueng-Cheng Yang,Tzu-Hao Cheng,Yijuang Chern,Bing-Wen Soong

Cell death discovery 7:372 PubMed34857740

2021

PIAS1 alleviates diabetic peripheral neuropathy through SUMOlation of PPAR-γ and miR-124-induced downregulation of EZH2/STAT3.

Applications

Unspecified application

Species

Unspecified reactive species

Zixin Hou,Ji Chen,Huan Yang,Xiaoling Hu,Fengrui Yang

Cell death & disease 12:1067 PubMed34753901

2021

Knockdown of ubiquitin-like modifier-activating enzyme 2 promotes apoptosis of clear cell renal cell carcinoma cells.

Applications

Unspecified application

Species

Unspecified reactive species

Guoxi Zhang,Junrong Zou,Jinglin Shi,Biao Qian,Kaiyang Qiu,Quanliang Liu,Tianpeng Xie,Zhihua He,Hui Xu,Yunfeng Liao,Yuting Wu,Yanmin Li,Guancheng Xiao,Yuanhu Yuan,Rihai Xiao,Gengqing Wu,Xiaofeng Zou

The Journal of biological chemistry 297:101200 PubMed34537242

2021

Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z.

Applications

Unspecified application

Species

Unspecified reactive species

Zhaosu Chen,Yunpeng Zhang,Qingqing Guan,Huifang Zhang,Jing Luo,Jialun Li,Wei Wei,Xiang Xu,Lujian Liao,Jiemin Wong,Jiwen Li

Frontiers in physiology 12:709506 PubMed34434118

2021

TRIM18-Regulated STAT3 Signaling Pathway PTP1B Promotes Renal Epithelial-Mesenchymal Transition, Inflammation, and Fibrosis in Diabetic Kidney Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Qi Chen,Chan Gao,Ming Wang,Xiao Fei,Ning Zhao
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com